BIVI
Price
$7.48
Change
-$0.07 (-0.93%)
Updated
Jul 25 closing price
Capitalization
13.89M
ITOS
Price
$10.17
Change
+$0.02 (+0.20%)
Updated
Jul 25 closing price
Capitalization
449.22M
12 days until earnings call
Interact to see
Advertisement

BIVI vs ITOS

Header iconBIVI vs ITOS Comparison
Open Charts BIVI vs ITOSBanner chart's image
BioVie
Price$7.48
Change-$0.07 (-0.93%)
Volume$24.22K
Capitalization13.89M
iTeos Therapeutics
Price$10.17
Change+$0.02 (+0.20%)
Volume$1.05M
Capitalization449.22M
BIVI vs ITOS Comparison Chart in %
Loading...
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIVI vs. ITOS commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIVI is a Hold and ITOS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (BIVI: $7.48 vs. ITOS: $10.17)
Brand notoriety: BIVI and ITOS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIVI: 15% vs. ITOS: 67%
Market capitalization -- BIVI: $13.89M vs. ITOS: $449.22M
BIVI [@Biotechnology] is valued at $13.89M. ITOS’s [@Biotechnology] market capitalization is $449.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIVI’s FA Score shows that 1 FA rating(s) are green whileITOS’s FA Score has 1 green FA rating(s).

  • BIVI’s FA Score: 1 green, 4 red.
  • ITOS’s FA Score: 1 green, 4 red.
According to our system of comparison, ITOS is a better buy in the long-term than BIVI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIVI’s TA Score shows that 6 TA indicator(s) are bullish while ITOS’s TA Score has 3 bullish TA indicator(s).

  • BIVI’s TA Score: 6 bullish, 4 bearish.
  • ITOS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BIVI is a better buy in the short-term than ITOS.

Price Growth

BIVI (@Biotechnology) experienced а -16.84% price change this week, while ITOS (@Biotechnology) price change was -0.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

BIVI is expected to report earnings on Nov 27, 2024.

ITOS is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ITOS($449M) has a higher market cap than BIVI($13.9M). ITOS YTD gains are higher at: 32.422 vs. BIVI (-62.600). BIVI has higher annual earnings (EBITDA): -18M vs. ITOS (-146.71M). ITOS has more cash in the bank: 520M vs. BIVI (8.01M). BIVI has less debt than ITOS: BIVI (366K) vs ITOS (5.05M). ITOS has higher revenues than BIVI: ITOS (35M) vs BIVI (0).
BIVIITOSBIVI / ITOS
Capitalization13.9M449M3%
EBITDA-18M-146.71M12%
Gain YTD-62.60032.422-193%
P/E RatioN/AN/A-
Revenue035M-
Total Cash8.01M520M2%
Total Debt366K5.05M7%
FUNDAMENTALS RATINGS
BIVI: Fundamental Ratings
BIVI
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIVIITOS
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEB3128.1119.73
+0.63%
Seaboard Corp
NTAP104.940.28
+0.27%
NetApp
SAMG16.41-0.13
-0.79%
Silvercrest Asset Management Group
EFXT8.02-0.17
-2.08%
Enerflex Ltd
SSKN1.96-0.06
-2.97%
Strata Skin Sciences

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with BMRN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
+0.20%
BMRN - ITOS
50%
Loosely correlated
-1.26%
IBO - ITOS
44%
Loosely correlated
+1.48%
BDTX - ITOS
43%
Loosely correlated
-4.81%
IMNM - ITOS
41%
Loosely correlated
-3.29%
OCUL - ITOS
40%
Loosely correlated
+2.43%
More